Skip to main content
. 2020 Sep 8;1(5):359–367. doi: 10.1016/j.hroo.2020.08.005

Table 1.

Echocardiographic parameters in the 4 studied groups

Control (n = 8) C+D (n = 8) Dantrolene+C+D (n = 7) Ivabradine+C+D (n = 8) ANOVA
P value
AWTd (mm) 1.19 ± 0.08 1.18 ± 0.06 1.19 ± 0.05 1.19 ± 0.07 >.05
AWTs (mm) 2.17 ± 0.13 2.16 ± 0.12 2.18 ± 0.11 2.17 ± 0.14 >.05
LVIDd (mm) 7.18 ± 0.58 7.12 ± 0.47 7.07 ± 0.20 7.31 ± 0.79 >.05
LVIDs (mm) 4.07 ± 0.65 4.00 ± 0.44 3.92 ± 0.41 4.20 ± 0.86 >.05
PWTd (mm) 1.23 ± 0.07 1.24 ± 0.06 1.22 ± 0.07 1.31 ± 0.09 >.05
PWTs (mm) 2.16 ± 0.13 2.19 ± 0.11 2.18 ± 0.15 2.18 ± 0.14 >.05
FS (%) 43.6 ± 6.8 43.7 ± 5.4 44.5 ± 6.3 42.8 ± 6.0 >.05

Values are mean ± SD.

ANOVA = analysis of variance; AWTd = left ventricular anterior wall thickness in diastole; AWTs = left ventricular anterior wall thickness in systole; C+D = caffeine + dobutamine; FS = left ventricular fractional shortening; LVIDd = left ventricular diameter in diastole; LVIDs = left ventricular diameter in systole; PWTd = left ventricular posterior wall thickness in diastole; PWTs = left ventricular posterior wall thickness in systole.